hellotayssir/FinQA_TAT-QA_financial_finetuning_dataset huggingface dataset:
EXECUTIVE OFFICERS OF THE REGISTRANT
Executive officers of our Company are appointed by the Board of Directors and serve at the discretion of the Board. The following table sets forth certain information with respect to all executive officers of our Company.
CHRISTOPHER H. ATAYAN has served in various senior executive positions with the Company since March 2006, including his service as Chairman of the Board since January 2008 and Chief Executive Officer since October 2006, and has been a director of the Company since 2004. Mr. Atayan has served as the Senior Managing Director of Slusser Associates, a private equity and investment banking firm, since 1988, and has been engaged in private equity and investment banking since 1982. He also serves on the Board of Eastek Holdings, LLC, a manufacturing company.
ANDREW C. PLUMMER has served as our President and Chief Operating Officer since October 2018, as our Chief Financial Officer since January 2007, and as our Secretary from January 2007 to October 2018. From 2004 to 2007, Mr. Plummer served our company in various roles including Acting Chief Financial Officer, Corporate Controller, and Manager of SEC Compliance. Prior to joining our company in 2004, Mr. Plummer practiced public accounting, primarily with the accounting firm Deloitte and Touche, LLP (now Deloitte).
CHARLES J. SCHMADERER has served as the Company’s Vice President and Corporate Controller since April 2018 and as Secretary since October 2018. From 2006 to 2018, Mr. Schmaderer served the Company in various roles including as the Vice President of Financial Reporting and Assistant Secretary, and as the Director of Financial and SEC Reporting. Prior to joining AMCON in 2006, Mr. Schmaderer practiced public accounting, primarily with the accounting firm Grant Thornton, LLP and also holds a Master of Business Administration (MBA).
Table:
Name | Age | Position
Christopher H. Atayan | 59 | Chairman of the Board, Chief Executive Officer, Director
Andrew C. Plummer | 45 | President, Chief Financial Officer, Director
Charles J. Schmaderer | 50 | Vice President, Corporate Controller, Secretary


Question: What is the average age of the company's Chief Executive and Chief Financial Officers?
Answer: 52
Calculation: (59 + 45)/2
8. Income Per Share
Basic income per share is calculated by dividing net earnings by the weighted average number of common shares outstanding for the applicable period. Diluted income per share is calculated after adjusting the denominator of the basic income per share calculation for the effect of all potential dilutive common shares outstanding during the period. The following table sets forth the computation of basic and diluted income per share:
For fiscal 2019, options and RSUs of 83,939 were excluded from the computation of diluted net income per share as their effect would have been anti-dilutive. For fiscal 2018 and fiscal 2017, the Company had no options or RSUs that were excluded from the computation of diluted net income per shares. RSAs for 594,382 shares in fiscal 2019, 363,413 shares in fiscal 2018 and 779,000 shares in fiscal 2017 were excluded from the calculation of diluted net income per share as these awards contain performance conditions that would not have been achieved as of the end of each reporting period had the measurement period ended as of that date.
Table:
 | April 27, 2019 | April 28, 2018 | April 29, 2017
Numerator: |  |  | 
Net Income (in millions) | $91.6 | $57.2 | $92.9
Denominator: |  |  | 
Denominator for Basic Earnings Per Share-Weighted Average Shares |  |  | 
Outstanding and Vested/Unissued Restricted Stock Units | 37,405,298 | 37,281,630 | 37,283,096
Dilutive Potential Common Shares-Employee Stock Options, |  |  | 
Restricted Stock Awards and Restricted Stock Units | 264,262 | 260,269 | 202,605
Denominator for Diluted Earnings Per Share | 37,669,560 | 37,541,899 | 37,485,701
Basic and Diluted Income Per Share: |  |  | 
Basic Income Per Share | $2.45 | $1.54 | $2.49
Diluted Income Per Share | $2.43 | $1.52 | $2.48


Question: What were the RSAs in 2019, 2018 and 2017 respectively?
Answer: 594,382, 363,413, 779,000
Purchased Intangible Assets
Purchased intangible assets include core and developed technology, in-process research and development, customer-related intangibles, acquisition-date backlog and other intangible assets. The estimated fair values of the core and developed technology and in-process research and development were determined based on the present value of the expected cash flows to be generated by the respective existing technology or future technology. The core and developed technology intangible assets are being amortized in a manner based on the expected cash flows used in the initial determination of fair value. In-process research and development is capitalized until such time as the related projects are completed or abandoned at which time the capitalized amounts will begin to be amortized or written off. Customer-related intangible assets consist of Atmel's contractual relationships and customer loyalty related to its distributor and end-customer relationships, and the fair values of the customerrelated intangibles were determined based on Atmel's projected revenues. An analysis of expected attrition and revenue growth for existing customers was prepared from Atmel's historical customer information. Customer relationships are being amortized in a manner based on the estimated cash flows associated with the existing customers and anticipated retention rates. Backlog relates to the value of orders not yet shipped by Atmel at the acquisition date, and the fair values were based on the estimated profit associated with those orders. Backlog related assets had a one year useful life and were being amortized on a straight line basis over that period. The total weighted average amortization period of intangible assets acquired as a result of the Atmel transaction is 9 years. Amortization expense associated with acquired intangible assets is not deductible for tax purposes. Thus, approximately $178.1 million was established as a net deferred tax liability for the future amortization of the intangible assets.
Table:
 | Weighted Average Useful Life | April 4, 2016
 | (in years) | (in millions)
Core and developed technology | 11 | $1,075.0
In-process research and development | — | 140.7
Customer-related | 6 | 630.6
Backlog | 1 | 40.3
Other | 5 | 1.8
Total purchased intangible assets |  | $1,888.4


Question: What was the Core and developed technology assets as a percentage of Total purchased intangible assets?
Answer: 56.93
Calculation: 1,075.0/1,888.4
Net debt
Net debt is a measure that provides valuable additional information on the summary presentation of the Group’s net financial liabilities and is a measure in common use elsewhere.
Prior to this quarter, all financial asset derivatives were current financial assets and so reduced net debt. Following a recent review we now also have financial asset derivatives that are non-current in nature. As all of these derivatives relate to financial liabilities, we continue to exclude them for the purposes of our net debt calculation and have expanded our definition to reflect this.
Net debt is now defined as the excess of total financial liabilities, excluding trade payables and other current liabilities, over cash, cash equivalents and other current financial assets, excluding trade and other current receivables, and non-current financial asset derivatives that relate to financial liabilities.
(a) Restated following adoption of IFRS 16. See note 1 and note 24 for further details.
Table:
 | € million | € million
 | 2019 | 2018
 |  | (Restated)(a)
Total financial liabilities | (28,257) | (26,738)
Current financial liabilities | (4,691) | (3,613)
Non-current financial liabilities | (23,566) | (23,125)
Cash and cash equivalents as per balance sheet | 4,185 | 3,230
Cash and cash equivalents as per cash flow statement | 4,116 | 3,090
Add bank overdrafts deducted therein | 69 | 140
Other current financial assets | 907 | 874
Non-current financial assets derivatives that relate to financial liabilities | 114 | –
Net debt | (23,051) | (22,634)


Question: What is the percentage change in Net Debt?
Answer: 1.84
Calculation: (23,051 / 22,634) - 1
* Recast to reflect segment changes.
The GTS gross profit margin increased 0.3 points year to year to 34.8 percent, due to the benefits of workforce actions and the continued scale out of our public cloud. We continued to take structural actions to improve our cost competitiveness and are accelerating the use of AI and automation in delivery operations, including leveraging Red Hat’s Ansible platform. Pre-tax income of $1,645 million decreased 7.6 percent, driven primarily by the decline in revenue and gross profit, and a higher level of workforce rebalancing charges in the current year. Pre-tax margin of 5.8 percent was essentially flat year to year, with the 2019 pre-tax margin reflecting benefits from structural and workforce actions.
Table:
($ in millions) |  |  | 
For the year ended December 31: | 2019 | 2018* | Yr.-to-Yr. Percent/ Margin Change
Global Technology Services |  |  | 
External total gross profit | $9,515 | $10,035 | (5.2)%
External total gross profit margin | 34.8% | 34.4% | 0.3pts.
Pre-tax income | $1,645 | $ 1,781 | (7.6)%
Pre-tax margin | 5.8% | 5.9% | (0.2)pts.


Question: What caused the decrease in the pre-tax income in 2019?
Answer: driven primarily by the decline in revenue and gross profit, and a higher level of workforce rebalancing charges in the current year.
(1) Includes construction costs capitalized related to build-to-suit facilities:
As of March 31, 2019 and 2018, the U.S. build-to-suit facility includes company-funded building improvements of $5.2 million and $4.5 million, respectively. In March 2019, the Company derecognized the U.K. build-to-suit facility upon substantial completion of construction. See Note 12 for further details.
Table:
 | As of March 31, | 
 | 2019 | 2018
U.S. build-to-suit facility | $47,001 | $43,925
U.K. build-to-suit facility | — | 31,240
Less: Accumulated depreciation | (5,164) | (753)
 | $41,837 | $74,412


Question: How much was the company-funded building improvements as of March 31, 2018?
Answer: $4.5 million
21. Supplemental Data
The following are additional required disclosures and other material items:
Table:
 |  | Years Ended June 30, | 
($ in millions) | 2019 | 2018 | 2017
Cost Data: |  |  | 
Repairs and maintenance costs | $120.4 | $108.0 | $99.1
Cash Flow Data: |  |  | 
Noncash investing and financing activities: |  |  | 
Noncash purchases of property, plant, equipment and software | $16.1 | $16.5 | $13.7
Cash paid (received) during the year for: |  |  | 
Interest payments, net | $27.6 | $29.5 | $27.7
Income tax payments (refunds), net | $27.5 | $33.7 | $(33.3)


Question: What was the Repairs and maintenance costs in 2019?
Answer: $120.4
Other income and expenses, net consisted of the following:
The Company receives significant public funding from governmental agencies in several jurisdictions. Public funding for research and development is recognized ratably as the related costs are incurred once the agreement with the respective governmental agency has been signed and all applicable conditions have been met.
R&D funding received in the year ended December 31, 2017 from the Nano2017 program with the French government is subject to a financial return in the year 2024 and depends on the future cumulative sales of a certain product group from 2019 to 2024. As such, an accrual amounting to $47 million was recorded as of December 31, 2019 compared to $42 million as of December 31, 2018.
Phase-out costs are costs incurred during the closing stage of a Company’s manufacturing facility. They are treated in the same manner as start-up costs. Start-up costs represent costs incurred in the start-up and testing of the Company’s new manufacturing facilities, before reaching the earlier of a minimum level of production or six months after the fabrication line’s quality certification.
Exchange gains and losses, net represent the portion of exchange rate changes on transactions denominated in currencies other than an entity’s functional currency and the changes in fair value of trading derivative instruments which are not designated as hedge and which have a cash flow effect related to operating transactions, as described in Note 27.
Patent costs include legal and attorney fees and payment for claims, patent pre-litigation consultancy and legal fees. They are reported net of settlements, if any, which primarily include reimbursements of prior patent litigation costs.
In 2019, gain on sale of businesses and non-current assets was related to the sale of one of our non-strategic assets. In 2018, it was related to the sale of one of the Company’s non-strategic investments while in 2017, it
was related to the sale of assets.
Table:
 | Year ended December 31, 2019 | Year ended December 31, 2018 | Year ended December 31, 2017
Research and development funding | 132 | 52 | 65
Phase-out and start-up costs | (38) | (1) | (8)
Exchange gain (loss), net | — | 4 | 4
Patent costs | (1) | (8) | (9)
Gain on sale of businesses and non-current assets | 7 | 8 | 4
Other, net | 3 | (2) | (1)
Total | 103 | 53 | 55


Question: What is the average Phase-out and start-up costs?
Answer: 15.67
Calculation: (38+1+8) / 3
Revenue and costs are generally directly attributed to our segments. However, due to the integrated structure of our business, certain revenue recognized and costs incurred by one segment may benefit other segments. Revenue from certain contracts is allocated among the segments based on the relative value of the underlying products and services, which can include allocation based on actual prices charged, prices when sold separately, or estimated costs plus a profit margin. Cost of revenue is allocated in certain cases based on a relative revenue methodology. Operating expenses that are allocated primarily include those relating to marketing of products and services from which multiple segments benefit and are generally allocated based on relative gross margin.
In addition, certain costs incurred at a corporate level that are identifiable and that benefit our segments are allocated to them. These allocated costs include costs of: legal, including settlements and fines; information technology; human resources; finance; excise taxes; field selling; shared facilities services; and customer service and support. Each allocation is measured differently based on the specific facts and circumstances of the costs being allocated. Certain corporate-level activity is not allocated to our segments, including restructuring expenses.
Segment revenue and operating income were as follows during the periods presented:
Corporate and Other operating loss comprised restructuring expenses.
Table:
(In millions) |  |  | 
Year Ended June 30, | 2019 | 2018 | 2017
Revenue |  |  | 
Productivity and Business Processes | $ 41,160 | $ 35,865 | $ 29,870
Intelligent Cloud | 38,985 | 32,219 | 27,407
More Personal Computing | 45,698 | 42,276 | 39,294
Total | $  125,843 | $   110,360 | $   96,571
Operating Income (Loss) |  |  | 
Productivity and Business Processes | $ 16,219 | $ 12,924 | $ 11,389
Intelligent Cloud | 13,920 | 11,524 | 9,127
More Personal Computing | 12,820 | 10,610 | 8,815
Corporate and Other | 0 | 0 | (306)
Total | $ 42,959 | $ 35,058 | $ 29,025


Question: How are operating expenses generally allocated?
Answer: Operating expenses that are allocated primarily include those relating to marketing of products and services from which multiple segments benefit and are generally allocated based on relative gross margin.
Plan Summaries
As of January 3, 2020, the Company had stock-based compensation awards outstanding under the following plans: the 2017 Omnibus Incentive Plan, 2006 Equity Incentive Plan, as amended, and the 2006 Employee Stock Purchase Plan, as amended ("ESPP"). Leidos issues new shares upon the issuance of the vesting of stock units or exercising of stock options under these plans.
In fiscal 2017, stockholders approved the 2017 Omnibus Incentive Plan which provides the Company and its affiliates' employees, directors and consultants the opportunity to receive various types of stock-based compensation awards, such as stock options, restricted stock units and performance-based awards, as well as cash awards.
The Company grants service-based awards that generally vest or become exercisable 25% a year over four years or cliff vest in three years. As of January 3, 2020, 4.4 million shares of Leidos' stock were reserved for future issuance under the 2017 Omnibus Incentive Plan and the 2006 Equity Incentive Plan.
The Company offers eligible employees the opportunity to defer restricted stock units into an equity-based deferred equity compensation plan, the Key Executive Stock Deferral Plan ("KESDP"). Prior to 2013, the Company offered an additional opportunity for deferrals into the Management Stock Compensation Plan ("MSCP"). Benefits from these plans are payable in shares of Leidos' stock that are held in a trust for the purpose of funding shares to the plans' participants.
Restricted stock units deferred under the KESDP are counted against the total shares available for future issuance under the 2017 Omnibus Incentive Plan. All awards under the MSCP are fully vested and the plan does not provide for a maximum number of shares available for future issuance.
The Company's ESPP allows eligible employees to purchase shares of Leidos' stock at a discount of up to 15% of the fair market value on the date of purchase. During the first half of fiscal 2018 and 2017, the discount was 5% of the fair market value on the date of purchase, thereby resulting in the ESPP being non-compensatory. Effective the second half of fiscal 2018, the Company increased the discount to 10% of the fair market value on the date of purchase, resulting in the ESPP being compensatory.
During fiscal 2019, 2018 and 2017, $25 million, $11 million and $10 million, respectively, was received from ESPP plan participants for the issuance of Leidos' stock. A total of 4.2 million shares remain available for future issuance under the ESPP.
Stock-based compensation and related tax benefits recognized under all plans were as follows:
Table:
 |  | Year Ended | 
 | January 3, 2020 | December 28, 2018 | December 29, 2017
 |  | (in millions) | 
Total stock-based compensation expense | $52 | $44 | $43
Tax benefits recognized from stock-based compensation | 13 | 11 | 17


Question: What was the change in the Tax benefits recognized from stock-based compensation from 2017 to 2018?
Answer: -6
Calculation: 11 - 17
Note 15 Leases
RIGHT-OF-USE ASSETS
BCE’s significant right-of-use assets under leases are satellites, office premises, land, cellular tower sites, retail outlets and OOH advertising spaces. Right-of-use assets are presented in Property, plant and equipment in the statement of financial position.
Table:
FOR THE YEAR ENDED DECEMBER 31, 2019 | NETWORK INFRASTRUCTURE AND EQUIPMENT | LAND AND BUILDINGS | TOTAL
COST |  |  | 
January 1, 2019 | 3,329 | 2,453 | 5,782
Additions | 527 | 513 | 1,040
Transfers | (233) | – | (233)
Acquired through business combinations | – | 8 | 8
Lease terminations | (12) | (38) | (50)
Impairment losses recognized in earnings | (2) | (3) | (5)
December 31, 2019 | 3,609 | 2,933 | 6,542
ACCUMULATED DEPRECIATION |  |  | 
January 1, 2019 | 1,042 | 536 | 1,578
Depreciation | 373 | 303 | 676
Transfers | (111) | – | (111)
Lease terminations | (3) | (22) | (25)
December 31, 2019 | 1,301 | 817 | 2,118
NET CARRYING AMOUNT |  |  | 
January 1, 2019 | 2,287 | 1,917 | 4,204
December 31, 2019 | 2,308 | 2,116 | 4,424


Question: What is the total net carrying amount on December 31, 2019?
Answer: 4,424
Summary of Consolidated Cash Flows
The below table summarizes the cash provided or used in our activities and the amount of the respective changes between the periods (in millions):
Operating Activities Cash provided by operating activities was $110.5 million for the year ended December 31, 2019 as compared to cash provided by operating activities of $341.4 million for the year ended December 31, 2018. The $230.9 million decrease was the result of the recapture of reinsurance treaties by our Insurance segment in 2018 and was offset in part by improved performance of the Insurance segment subsequent to the KIC acquisition, significant reduction of losses at the Broadcasting segment driven by the cost cutting measures, and an increase in the working capital at our Telecommunications segments.
Investing Activities Cash used in investing activities was $263.7 million for the year ended December 31, 2019 as compared to cash used in investing activities of $224.6 million for the year ended December 31, 2018. The $39.1 million increase in cash used was a result of (i) an increase in net cash spent at our Insurance segment driven by purchases of investments from the residual cash received from the KIC acquisition and reinsurance recaptures in 2018, (ii) a decrease in cash proceeds received at our Life Sciences segment, from the 2018 upfront payment and 2019 escrow release related to the sale of BeneVir in the prior period, and (iii) an increase in cash used at our Energy segment to acquire ampCNG stations in 2019. These decreases were largely offset by a reduction in cash used by our Construction segment, driven by the acquisition of GrayWolf in 2018, and a reduction in cash used by our Broadcasting segment as less cash was used on its acquisitions in the current year compared to 2018.
This was largely offset by a reduction in net cash used by the Insurance segment's purchases of investments, as in the prior period the Insurance segment purchased investments from the cash received from the acquisition of KIC.
Financing Activities Cash provided by financing activities was $62.4 million for the year ended December 31, 2019 as compared to $115.2 million for the year ended December 31, 2018. The $52.8 million decrease was a result of a decrease in net borrowings by the Construction and Broadcasting segments, and offset in part by the increase in net borrowings by the Energy segment and Corporate segment, and a decline in cash paid to noncontrolling interest holders driven by the proceeds from our Life Sciences segment's sale of BeneVir in 2018.
Table:
Years Ended December 31, |  |  | 
 | 2019 | 2018 | Increase / (Decrease)
Operating activities | $110.5 | $341.4 | $(230.9)
Investing activities | (263.7) | (224.6) | (39.1)
Financing activities | 62.4 | 115.2 | (52.8)
Effect of exchange rate changes on cash and cash equivalents | 1.0 | (0.5) | 1.5
Net decrease in cash,cash equivalents and restricted cash | $(89.8) | $231.5 | $(321.3)


Question: What is the average investing activities?
Answer: -244.15
Calculation: -(263.7 + 224.6) / 2
22. Cash and cash equivalents
Cash at bank earns interest at floating interest rates. Of the total cash and cash equivalents balance, $79.3 million (2018 $63.9 million) is callable at notice of three months or less at the date of investment.
Short-term bank deposits are made for varying periods of between one day and three months depending on the cash requirements of the Group and earn interest at the short-term deposit rates appropriate for the term of the deposit and currency.
At the end of 2019, the currency split of cash and cash equivalents was US Dollar 78 per cent (2018 83 per cent), Sterling 11 per cent (2018 8 per cent) and other currencies 11 per cent (2018 9 per cent).
For the purposes of the cash flow statement, cash and cash equivalents comprise the above amounts.
Table:
 | 2019 | 2018
 | $ million | $ million
Cash at bank | 103.9 | 57.7
Short-term bank deposits | 79.3 | 63.9
 | 183.2 | 121.6


Question: What are short-term bank deposits made for?
Answer: varying periods of between one day and three months depending on the cash requirements of the Group and earn interest at the short-term deposit rates appropriate for the term of the deposit and currency.